Novel drugs that target the metabolic reprogramming in renal cell cancer

Overview of attention for article published in Cancer & Metabolism, July 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#34 of 205)
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

facebook: 1 Facebook page
f1000: 1 research highlight platform

Citations

dimensions_citation: 64 Dimensions

Readers on

mendeley: 99 Mendeley

Summary News X Facebook Research highlights Dimensions citations

So far, Dimensions has found 64 publications that cite this research output.

64

The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.

Research Progress of Metabolic Syndrome and Renal Cancer

Article in annals of urologic oncology (March 2024)

Complex I activity in hypoxia: implications for oncometabolism

Article in Biochemical Society Transactions (March 2024)

Immuno-metabolic reprogramming of T cell: a new frontier for pharmacotherapy of Rheumatoid arthritis

Article in Immunopharmacology and Immunotoxicology (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.